Randomized trial demonstrates improved glycemic control in Latino adults with prediabetes, indicating potential for effective digital education interventions.
Introduction and Objective: We evaluated whether a newly developed community health worker co-produced CGM-informed digital education intervention, My Control!, improves glycemic control to a clinically meaningful degree in Latino adults with prediabetes. Methods: In the Trial 1 (NCT06472297) intervention development study, N=20 Latino community health workers with prediabetes risk self-monitored with a CGM for 20 days. High glucose alerts were set at 140mg/dL and low alerts were disabled. Participants received real-time feedback and submitted daily smartphone video reflections prompted by high glucose excursions. AI-assisted transcription and editing supported development of fourteen educational videos. In Trial 2 (NCT06883812), N=30 adults with lab confirmed prediabetes completed an experimental AB design with a 10-day masked CGM followed by a 10-day unmasked phase paired with daily My Control! videos sent by text. Glucose profile outcomes included mean glucose and time above range (TAR) 140mg/dL, and Wilcoxon tests were applied to study phase contrasts. Results: In Trial 1, all participants completed CGM wear yielding 95% valid CGM data on at least 83% of study days. A total of 723 minutes of video were generated to produce 14 videos comprising My Control!. In Trial 2, masked to unmasked contrast showed decreased TAR with 52% (14 of 27) achieving greater than the 5% criterion reduction and median change of -6.4% (Q1 -11.6, Q3 1.4; p=.02). Mean glucose also decreased with median change of -3.7mg/dL (Q1 -10.6, Q3 3.6; p=.049). Conclusion: My Control! is a community health worker-supported CGM intervention demonstrating feasible implementation and plausible clinically meaningful improvements in glycemic metrics among Latino adults with prediabetes. This biosensor-informed behavioral model positions CGM as an engaging tool to support early glycemic self-regulation in prediabetes. Disclosure D. Black: None. Funding Funding support provided by a federal P50 Center grant from the National Institutes of Health (NIMHHD award 3P50MD017344-03S3) to author DB who was the PI of center project 4. The funder had no role in any part of the study other than funding.
No takes yet. Share an insight, caveat, or question.
DAVID BLACK (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: